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When your heart depends on your gut feelings
Cuando el corazón depende del tracto digestivo
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The epidemiology, microbiology, and diagnosis of infective
endocarditis (IE) has changed rapidly over the last 50 years. The
International Collaboration on Endocarditis (ICE) study1 reported
that the most prevalent causes of IE were degenerative valve
disease and the presence of prosthetic valves (in the 1960s and
1970s the main causes were rheumatic lesions). Moreover, the
very recent EURO-ENDO observational study has highlighted a
change in the microbiology of IE—the most prevalent causative
microorganisms are staphylococci (44%), followed by enterococci
(15.8%), oral streptococci (12.3%), and Streptococcus gallolyticus
(6.6%)—and enterococci are no longer the third cause of IE, as they
were at the time of the ICE study, and have become the second
cause. This is probably due to the increasing proportion of older
patients with comorbidities affected by IE, which also makes IE a
disease with poor prognosis.2
Gut permeability and inflammation, being more prevalent in
the older population, could explain gut bacteria ‘‘leakage’’ in the
systemic circulation, potentially causing not only cardiovascular
but also autoimmune diseases.3 Enterococci are the most abundant
bacteria in the human gastrointestinal tract (small and large
intestine), representing 1% of the human fecal flora, with
Enterococcus faecalis and Enterococcus faecium being the 2 main
species of the enterococcus genus. In healthy individuals,
enterococci play a commensal/probiotic role but, in elderly people,
who are more frequently affected by dysbiosis (an imbalance in the
community of healthy human gut microbiota), bacteria can cross
the mucosa of the gut and enter the circulation. One of the many
ways the microbiota maintain intestinal homeostasis is by
stimulating goblet cell secretion of mucin, which is a thick layer
protecting the colonic epithelium from intestinal microbes.
Whenever this commensal role is not achieved, bacteria can enter
the circulation and colonize other areas of the body and form
biofilms.4 Chronic dysbiosis associated with other factors, such as
genetics and diet-derived chemical irritants, can induce chronic
colonic inflammation and lead to colorectal diseases and colorectal
neoplasia (CRN), which can progress to colorectal cancer (CRC).5
Enterococci are not the only bacteria able to cross the mucosa of
the colon, S. gallolyticus, which is, however, not present in most
human gut (2.5%-15% of healthy humans), also has this property.
S. gallolyticus bacteremia has been extensively studied and the
mechanism of translocation and dissemination is well understood.
Translocation happens through surface-exposed adhesins allowing
adhesion to host cells, whereas dissemination involves the pilus
(Pil3 expression), which binds to plasma fibrinogen. Once in the
blood stream, Pil1 expression is responsible for the binding to
collagen I (present on the surfaces of damaged heart valves),
achieving heart colonization.6 As long ago as the 1970s,
S. gallolyticus bacteremia was found to be associated with both
CRN and IE.7
In contrast, the mechanism of E. faecalis bacteremia is less well
known. Although the main portal of entry of E. faecalis is the
genitourinary tract, it has been shown that E. faecalis overgrowth
can stimulate reactive oxygen species production and induce
genomic instability in colonic cells, favoring lesions of the
intestinal mucosa and translocation of E. faecalis in the blood
circulation8 (figure 1).
Supporting the hypothesis of the gastroenteric tract as a portal
of entry of E. faecalis bacteremia, a study published in 2017 by
Pericàs et al. explored the relationship between E. faecalis IE (EFIE)
and CRN. These authors examined the prevalence of colorectal
neoplasms in EFIE patients whose presumed source of infection
could not be determined and found that 50.8% had CRN. In the
group of patients with an identified portal of entry of the infection,
only 6 patients underwent colonoscopy and 1 of them was
diagnosed with CRN (16.7%); therefore no conclusions could be
drawn for this group.9
In an article by Escolà-Vergé et al.,10 recently published in
Revista Española de Cardiologı́a, the authors aimed to determine
the prevalence of colorectal disease in EFIE patients, irrespective of
the hypothesized source of infection. The rationale behind their
study was based on the fact that 5% of patients with IE (all
etiologies) would experience recurrent infection with a higher
mortality risk, the reason being a potential undiagnosed colorectal
disease (portal of entry of bacteria into the circulation). If this
hypothesis is correct, performing a colonoscopy, which
could identify and treat the upstream cause of the endocarditis,
would decrease the risk of recurrence. In their study, the authors
included all consecutive episodes (n = 103) with EFIE seen in
4 referral centers (3 centers in Spain and 1 in Italy). Patients were
classified based on the presumed source of infection into patients
with ‘‘unknown portal of entry’’ and patients with ‘‘known portal of
entry’’. Only 70 EFIE patients underwent colonoscopy (6 months
before or after the EFIE diagnosis): patients with an ‘‘unknown
portal of entry’’ were more numerous than those with an
‘‘known portal of entry’’ (64% vs 36%).
Comparison of demographic and clinical characteristics be-
tween the 2 groups revealed that health care-associated infections
were more prevalent in patients with a ‘‘known portal of entry’’
than in those with an ‘‘unknown portal of entry’’ (83% vs 29%,
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